RaQualia Pharma Inc.
4579.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥495,031 | -¥323,662 | ¥851,011 | ¥880,579 |
| Dep. & Amort. | ¥401,653 | ¥175,564 | ¥147,731 | ¥141,555 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥51,960 | -¥460,310 | ¥677,220 | -¥459,601 |
| Other Non-Cash | ¥222,363 | -¥110,188 | -¥195,878 | -¥196,506 |
| Operating Cash Flow | ¥180,945 | -¥718,596 | ¥1,480,084 | ¥366,027 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥96,707 | -¥222,205 | -¥31,905 | -¥105,418 |
| Net Acquisitions | -¥3,879,637 | ¥0 | ¥0 | -¥13,924 |
| Inv. Purchases | -¥200,000 | -¥260,000 | -¥951,634 | -¥718,159 |
| Inv. Sales/Matur. | ¥358,563 | ¥350,000 | ¥935,891 | ¥543,828 |
| Other Inv. Act. | ¥152,171 | -¥3,168 | -¥1 | ¥14,422 |
| Investing Cash Flow | -¥3,665,610 | -¥135,373 | -¥47,649 | -¥279,251 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥2,902,172 | ¥39,880 | ¥11,790 | -¥18,297 |
| Stock Issued | ¥80,014 | ¥786,566 | ¥4,033 | ¥1,855 |
| Stock Repurch. | -¥80 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | ¥80,013 | -¥52,358 | -¥45,386 | ¥1 |
| Financing Cash Flow | ¥2,982,105 | ¥793,450 | -¥29,563 | -¥16,441 |
| Forex Effect | -¥20,251 | ¥45,953 | ¥35,771 | ¥109,010 |
| Net Chg. in Cash | -¥522,809 | -¥14,566 | ¥1,438,643 | ¥179,345 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥3,664,738 | ¥3,679,304 | ¥2,240,661 | ¥2,061,316 |
| End Cash | ¥3,141,929 | ¥3,664,738 | ¥3,679,304 | ¥2,240,661 |
| Free Cash Flow | ¥84,238 | -¥940,801 | ¥1,448,179 | ¥260,609 |